Company: NE-WTA
Filing Date: 2025-04-22
Form Type: DEFA14A
Source: 0001628280-25-018699
Chunk: 1

Company: Noble Corp plc
Filing Date: 2025-04-22
Form: DEFA14A
Chunk 1
---
 to shareholders on or about April 22, 2025.

We are providing this Supplement to confirm and clarify the terms by which we may conduct share repurchases as further described in the section of the Proxy Statement entitled “Resolution 15 – Approve the Terms of the Agreements and Counterparties Pursuant to Which we may Purchase our Class A Ordinary Shares” (“Relevant Section”). The Relevant Section has been revised to confirm and clarify that any share repurchase program would be implemented in conjunction with our brokers and other financial institutions that are Approved Counterparties (as defined below) through open market transactions at market prices and consistent with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or Rule 10b-18 under the Exchange Act), as reproduced below.

Except as described in this Supplement, none of the items or information presented in the Proxy Statement is affected by this Supplement. No amendment is being made to the section of the Proxy Statement entitled “Notice of 2025 Annual General Meeting of Shareholders” or to those parts of the Proxy Statement that are cross-referred to in that section. This Supplement does not provide all of the information that is important to your voting decisions at the Meeting. The Proxy Statement contains other important additional information. We encourage you to carefully read this Supplement together with the Proxy Statement.

<div align='center'>2</div>

______________________________________________________________________________

Resolution 15

Approve the Terms of the Agreements and Counterparties Pursuant to which we may Purchase our Class A Ordinary Shares

The SEC and the NYSE do not require shareholder approval for share repurchases, however, un der the UK Companies Act, we, like other UK companies, are prohibited from purchasing our outstanding shares unless such purchase has been approved by a resolution of our shareholders. The approval of share repurchases being sought is limited to 23,800,068 shares, r epresenting 14.99% of the issued and outstanding share capital of the Company as of March 10, 2025 (being the latest practicable date prior to the publication of the notice of meeting). UK companies may purchase their own shares by “market” purchases or “off-market” purchases. Any purchase by a UK company of its own shares other than on a recognized investment exchange is considered to be an “off-market” purchase. The NYSE, which is the only exchange on which our shares are traded, does not fall within the definition of a “recognized